Formosa patents expiration
1. Clobetasol Propionate patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11376262 | FORMOSA | Method of treating an inflammatory or infectious disease |
May, 2036
(12 years from now) | |
| US10588913 | FORMOSA | Aqueous suspension agent containing glucocorticosteroid nanoparticles |
May, 2036
(12 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Mar 04, 2027 |
Drugs and Companies using CLOBETASOL PROPIONATE ingredient
Market Authorisation Date: 04 March, 2024
Treatment: Treatment of inflammation
Dosage: SUSPENSION/DROPS;OPHTHALMIC
More Information on Dosage
CLOBETASOL PROPIONATE family patents
